Caxton

Latest statistics and disclosures from Caxton Corp's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RZLT, GLD, BRK.B, MNMD, ELVN, and represent 97.03% of Caxton Corp's stock portfolio.
  • Added to shares of these 5 stocks: RZLT, GLD, CMPX, SABS, BRK.B.
  • Started 1 new stock position in SABS.
  • Reduced shares in these 1 stock: MNMD.
  • Caxton Corp was a net buyer of stock by $4.4M.
  • Caxton Corp has $23M in assets under management (AUM), dropping by 132.00%.
  • Central Index Key (CIK): 0001388551

Tip: Access up to 7 years of quarterly data

Positions held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Caxton Corp

Caxton Corp holds 12 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Rezolute Com New (RZLT) 81.7 $19M +23% 2.0M 9.40
 View chart
Spdr Gold Tr Gold Shs (GLD) 11.3 $2.6M +47% 7.3k 355.47
 View chart
Berkshire Hathaway Inc Del Cl B New (BRK.B) 1.4 $328k +3% 651.00 503.00
 View chart
Mind Medicine Mindmed Com New (MNMD) 1.4 $319k -20% 27k 11.79
 View chart
Enliven Therapeutics (ELVN) 1.2 $268k 13k 20.47
 View chart
Compass Therapeutics (CMPX) 0.8 $187k +23% 54k 3.50
 View chart
Bicara Therapeutics (BCAX) 0.8 $173k 11k 15.79
 View chart
Kyverna Therapeutics (KYTX) 0.6 $138k 23k 6.00
 View chart
Lexeo Therapeutics (LXEO) 0.5 $115k 17k 6.64
 View chart
Inhibikase Therapeutics Com New (IKT) 0.1 $27k 16k 1.62
 View chart
Sab Biotherapeutics Com New (SABS) 0.1 $22k NEW 11k 2.01
 View chart
Context Therapeutics (CNTX) 0.1 $18k 18k 0.97
 View chart

Past Filings by Caxton Corp

SEC 13F filings are viewable for Caxton Corp going back to 2013

View all past filings